Have a feature idea you'd love to see implemented? Let us know!

NDRA ENDRA Life Sciences Inc

Price (delayed)

$6.06

Market cap

$250,848

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1,382.5

Enterprise value

-$5.87M

ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), a ground-breaking technology being developed to visualize tissue like MRI, but at 1/50th the cost and at the ...

Highlights
NDRA's equity has surged by 143% since the previous quarter and by 30% year-on-year
The company's quick ratio has surged by 100% YoY

Key stats

What are the main financial stats of NDRA
Market
Shares outstanding
41,394
Market cap
$250,848
Enterprise value
-$5.87M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$9.57M
EBITDA
-$9.33M
Free cash flow
-$9.01M
Per share
EPS
-$1,382.5
Free cash flow per share
-$578.03
Book value per share
$1,426.25
Revenue per share
$0
TBVPS
$669.82
Balance sheet
Total assets
$10.44M
Total liabilities
$1.45M
Debt
$281,154
Equity
$8.99M
Working capital
$5.36M
Liquidity
Debt to equity
0.03
Current ratio
4.97
Quick ratio
4.74
Net debt/EBITDA
0.66
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-128.1%
Return on equity
-162.5%
Return on invested capital
-320.2%
Return on capital employed
-105.2%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NDRA stock price

How has the ENDRA Life Sciences stock price performed over time
Intraday
2.36%
1 week
-37.97%
1 month
-10.36%
1 year
-99.66%
YTD
-99.84%
QTD
-13.92%

Financial performance

How have ENDRA Life Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$9.17M
Net income
-$9.57M
Gross margin
N/A
Net margin
N/A
The operating income rose by 28% year-on-year and by 8% since the previous quarter
ENDRA Life Sciences's net income has increased by 22% YoY and by 3.3% from the previous quarter

Growth

What is ENDRA Life Sciences's growth rate over time

Valuation

What is ENDRA Life Sciences stock price valuation
P/E
N/A
P/B
0
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS has surged by 77% YoY and by 31% QoQ
NDRA's equity has surged by 143% since the previous quarter and by 30% year-on-year
NDRA's P/B is 100% less than its 5-year quarterly average of 3.4 and 100% less than its last 4 quarters average of 1.7

Efficiency

How efficient is ENDRA Life Sciences business performance
The company's return on invested capital rose by 20% YoY and by 4.2% QoQ
The return on equity has grown by 12% since the previous quarter and by 4.2% year-on-year
The ROA has increased by 7% since the previous quarter

Dividends

What is NDRA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NDRA.

Financial health

How did ENDRA Life Sciences financials performed over time
NDRA's total assets has soared by 106% since the previous quarter and by 13% year-on-year
The company's quick ratio has surged by 100% YoY
The debt is 97% less than the equity
NDRA's equity has surged by 143% since the previous quarter and by 30% year-on-year
The debt to equity has shrunk by 67% QoQ and by 57% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.